SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
The Rock-Star Investors Next Door
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

3 pts

Opinion on  Immucor Inc (BLUD)     Sector: Healthcare  >  Industry: Medical Equipment & Supplies
Immucor Inc

Aug 05, 2008 12:11 PM UTC
Foto
Return Risk
-36.63% HIGH
Principal

Immucor  is out for blood that is testing blood for antibodies and other serum components prior to transfusions. With its acquisition of Gamma Biologicals and Biopool International in the past decade, this market leader in blood testing systems sales has had a 2,893% rate of return. Rising stock prices from $1.14 in 97 to $33.39 in 07 has been a result of its worldwide expansion. Their recent double-digit sales growth is generating investor interest today. A covered call investing position for BLUD is currently available for August  stock options expiration with a potential return of 2.9%


BLUD:  This call was made on 08/05/08 @ $31.46
Rating:   Positive   $31.46 (08/05/08)
Gain/Loss:   -28.35% in 108 days
Target:   $39.00 (+23.97%) in > one year
Allocation:   0.0% of portfolio


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 29.65 +61.65% 160
2 21.24 +48.89% 50
3 19.00 +49.44% 205
4 17.77 +19.60% 4
5 15.63 +16.16% 6


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Immucor Inc (BLUD)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
86.5%
Top:
100.0%




Latest Picks by Marian Filo
Symbol SP Sentiment Rating Return Since
GMED N/A Positive +11.76% 11/18/08
TWM Positive +33.37% 11/18/08
DHBR N/A Positive +6.00% 11/18/08
XTLB N/A Positive -59.30% 11/18/08
TSLI N/A Positive -71.43% 11/17/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch